212 related articles for article (PubMed ID: 26290499)
1. Ketamine's potential as a rapid antidepressant was overplayed.
Zhang MW; Ho RC
BMJ; 2015 Aug; 351():h4467. PubMed ID: 26290499
[No Abstract] [Full Text] [Related]
2. Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression.
Xu AJ; Niciu MJ; Lundin NB; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Machado-Vieira R; Zarate CA
Neural Plast; 2015; 2015():858251. PubMed ID: 26137324
[TBL] [Abstract][Full Text] [Related]
3. Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression.
Yang JJ; Wang N; Yang C; Shi JY; Yu HY; Hashimoto K
Biol Psychiatry; 2015 Feb; 77(3):e19-e20. PubMed ID: 25104172
[No Abstract] [Full Text] [Related]
4. Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder.
Niciu MJ; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Furey ML; Zarate CA
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539512
[TBL] [Abstract][Full Text] [Related]
5. Concurrent Use of Buprenorphine, Methadone, or Naltrexone Does Not Inhibit Ketamine's Antidepressant Activity.
Marton T; Barnes DE; Wallace A; Woolley JD
Biol Psychiatry; 2019 Jun; 85(12):e75-e76. PubMed ID: 30926131
[No Abstract] [Full Text] [Related]
6. [Ketamine's antidepressant effect: focus on ketamine mechanisms of action].
De Maricourt P; Jay T; Goncalvès P; Lôo H; Gaillard R
Encephale; 2014 Feb; 40(1):48-55. PubMed ID: 24434007
[TBL] [Abstract][Full Text] [Related]
7. Ketamine as a novel antidepressant: from synapse to behavior.
Murrough JW
Clin Pharmacol Ther; 2012 Feb; 91(2):303-9. PubMed ID: 22205190
[TBL] [Abstract][Full Text] [Related]
8. Synaptic potentiation and rapid antidepressant response to ketamine in treatment-resistant major depression: A replication study.
Nugent AC; Wills KE; Gilbert JR; Zarate CA
Psychiatry Res Neuroimaging; 2019 Jan; 283():64-66. PubMed ID: 30551012
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation.
Gilbert JR; Zarate CA
Pharmacol Biochem Behav; 2020 Feb; 189():172856. PubMed ID: 31958471
[TBL] [Abstract][Full Text] [Related]
10. Ketamine's rapid antisuicidal effects are not attenuated by Buprenorphine.
Hosanagar A; Schmale A; LeBlanc A
J Affect Disord; 2021 Mar; 282():252-254. PubMed ID: 33418374
[TBL] [Abstract][Full Text] [Related]
11. Ketamine: Future Treatment For Unresponsive Depression?
Frere M; Tepper J
Ir Med J; 2016 Sep; 109(8):453. PubMed ID: 28124853
[TBL] [Abstract][Full Text] [Related]
12. Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression.
Sos P; Klirova M; Novak T; Kohutova B; Horacek J; Palenicek T
Neuro Endocrinol Lett; 2013; 34(4):287-93. PubMed ID: 23803871
[TBL] [Abstract][Full Text] [Related]
13. Ketamine for depression.
Jelen LA; Stone JM
Int Rev Psychiatry; 2021 May; 33(3):207-228. PubMed ID: 33569971
[TBL] [Abstract][Full Text] [Related]
14. A historical review of antidepressant effects of ketamine and its enantiomers.
Wei Y; Chang L; Hashimoto K
Pharmacol Biochem Behav; 2020 Mar; 190():172870. PubMed ID: 32035078
[TBL] [Abstract][Full Text] [Related]
15. Motor-Activity Markers of Circadian Timekeeping Are Related to Ketamine's Rapid Antidepressant Properties.
Duncan WC; Slonena E; Hejazi NS; Brutsche N; Yu KC; Park L; Ballard ED; Zarate CA
Biol Psychiatry; 2017 Sep; 82(5):361-369. PubMed ID: 28457485
[TBL] [Abstract][Full Text] [Related]
16. [Ketamine--a new treatment option for therapy-resistant depression].
Köhler S; Betzler F
Fortschr Neurol Psychiatr; 2015 Feb; 83(2):91-7. PubMed ID: 25723773
[TBL] [Abstract][Full Text] [Related]
17. Intravenous ketamine for treatment-resistant major depressive disorder.
Covvey JR; Crawford AN; Lowe DK
Ann Pharmacother; 2012 Jan; 46(1):117-23. PubMed ID: 22190250
[TBL] [Abstract][Full Text] [Related]
18. Ketamine helps a third of patients with treatment resistant depression, finds small UK study.
Torjesen I
BMJ; 2014 Apr; 348():g2576. PubMed ID: 24699320
[No Abstract] [Full Text] [Related]
19. The promise of ketamine for treatment-resistant depression: current evidence and future directions.
DeWilde KE; Levitch CF; Murrough JW; Mathew SJ; Iosifescu DV
Ann N Y Acad Sci; 2015 May; 1345(1):47-58. PubMed ID: 25649308
[TBL] [Abstract][Full Text] [Related]
20. Metabolomic signatures of intravenous racemic ketamine associated remission in treatment-resistant depression: A pilot hypothesis generating study.
Singh B; MahmoudianDehkordi S; Voort JLV; Han X; Port JD; Frye MA; Kaddurah-Daouk R;
Psychiatry Res; 2022 Aug; 314():114655. PubMed ID: 35738038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
